COMMUNIQUÉS West-GlobeNewswire

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
27/07/2026
Board appointment adds proven medical device leadership MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive [...]
Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer
27/07/2026
MILLBRAE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet [...]
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update
27/07/2026
Kennewick, WA, July 27, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ , is pleased to share this update on the meaningful advancements the [...]
SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity
27/07/2026
TEL AVIV, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its board of directors has made a decision to target the agentic artificial intelligence [...]
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
27/07/2026
— First patient enrolled in Part B of Phase 2 ASCEND study enabled by availability of drug product from new manufacturing process — — Topline data from Part A of Phase 2 ASCEND study remains on track for end of year — [...]
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
27/07/2026
SAN DIEGO, July 27, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, [...]
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
27/07/2026
Company plans to submit an IND in the fourth quarter of 2026 and to initiate Phase 1 study by the end of 2026 WATERTOWN, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA) a clinical- [...]
ITM Introduces Lumara Bio as Its New Oncology Therapeutics Division
27/07/2026
Lumara Bio brings together ITM's existing pipeline of early- and late-stage radiopharmaceutical therapies, including lead drug candidate 177 Lu-edotreotide (ITM-11), into a single, dedicated division New drug [...]
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
27/07/2026
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growth FB102 Phase 1b studies in vitiligo and celiac [...]
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
27/07/2026
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region Allschwil, Switzerland – July 27, 2026 Idorsia Ltd (SIX: IDIA) has [...]
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
27/07/2026
ROCKVILLE, Md. and SUZHOU, China, July 26, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the [...]
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
26/07/2026
ALISO VIEJO, Calif., July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on July 24, 2026, RxSight granted inducement stock options to purchase a total of 571,286 shares of RxSight’s [...]
SugarReset Official Lunch2026 Natural Blood Sugar Support Drops for Healthy Glucose Levels Available in USA, Sugar Reset Highlights Ingredient, Supplement Facts
26/07/2026
Discover everything you need to know about SugarReset Blood Sugar Drops in this comprehensive guide. Learn how this natural blood sugar supplement supports healthy blood sugar levels. Read our detailed Sugar Reset [...]
BloodPril Launch 2026 Natural Blood Pressure Support Capsule Highlights Ingredients, Supplement Facts Available Blood Pril in the USA
26/07/2026
BloodPril is a effective blood pressure support supplement formulated with carefully selected natural ingredients and essential nutrients to help maintain healthy blood pressure levels already within the normal range, [...]
CogniHoney Opens Up Its 2026 Formula: What the Four-Ingredient Label Shows About Baobab Fiber and Spermidine
26/07/2026
Cogni Honey Publishes Updated Ingredient, Serving, Label, and Safety Information for Its Current Dietary Supplement Formula Largo, FL, July 25, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
ARCPOINT PROVIDES LEADERSHIP UPDATE
25/07/2026
GREENVILLE, South Carolina, July 24, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces today that Peter Kendall has stepped down as Interim Chief Executive Officer of the Company [...]
HorseFil Publishes Full Milligram Amounts for All Seven Ingredients: Tongkat Ali 200 mg, Serving Directions, and Safety Information for 2026
25/07/2026
HorseFil's Tongkat Ali, Maca Root, Ashwagandha, and Horny Goat Weed Amounts Per Gummy Ogden, UT, July 24, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the Food and Drug Administration. HorseFil [...]
LifeMD to Report Second Quarter 2026 Financial Results on August 5
24/07/2026
NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, [...]
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
24/07/2026
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, [...]

Pages